🇺🇸 Sr-89 in United States

22 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 22

Most-reported reactions

1. Infection — 3 reports (13.64%)
2. Pain — 3 reports (13.64%)
3. Anaemia — 2 reports (9.09%)
4. Anxiety — 2 reports (9.09%)
5. Back Pain — 2 reports (9.09%)
6. Bone Disorder — 2 reports (9.09%)
7. Bronchitis — 2 reports (9.09%)
8. Cardiomegaly — 2 reports (9.09%)
9. Constipation — 2 reports (9.09%)
10. Death — 2 reports (9.09%)

Source database →

Frequently asked questions

Is Sr-89 approved in United States?

Sr-89 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Sr-89 in United States?

Peking Union Medical College Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.